Skip to main content
Smart Investors Daily
IT

OTC · ITNS

Itonis, Inc.

Healthcare · Medical - Distribution

$0.00

Up+$0.00 (+0.00%)

Updated Oct 9, 2026, 4:53 AM

SID Score

2.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
457.02K
P/E ratio
-46.21
Dividend yield
0.00%
52-week range
$0.00 – $0.00
Volume
6.66K
Avg. volume
845.57K

Price performance · ITNS

ITNS price history

1M range · 9 trading sessions · Daily adjusted prices

Prices through Oct 7, 2026

ITNS closed at $0.00 after 9 trading sessions, up 33.33% for the selected period.

Last close
$0.00
Period change
+33.33%
Period low
$0.00
Period high
$0.00
Daily close
View OHLC price history
ITNS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 7, 2026$0.0003$0.0004$0.0003$0.00046.66K
Oct 6, 2026$0.0003$0.0004$0.0003$0.0004181.86K
Sep 29, 2026$0.0003$0.0004$0.0003$0.00045.26K
Sep 28, 2026$0.0003$0.0004$0.0003$0.0004149.19K
Sep 22, 2026$0.0003$0.0004$0.0003$0.0004502.66K
Sep 18, 2026$0.0004$0.0004$0.0004$0.0004750K
Sep 16, 2026$0.0003$0.0004$0.0003$0.00041M
Sep 15, 2026$0.0004$0.0004$0.0004$0.00042.66K
Sep 14, 2026$0.0003$0.0003$0.0003$0.00031M

Latest ITNS news

The latest Smart Investors Daily articles mentioning ITNS.

ITNS research

Overview

Company profile and research snapshot.

Company profile

ITONIS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 5, 2026

Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl

Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis’s over-the-counter (OTC) nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product. Under the terms of the agreement, Caring Brands will assume respo

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.